How many times has Johnson and Johnson stock split?
Johnson & Johnson stock (symbol: JNJ) underwent a total of 6 stock splits.
What does the J&J split mean for shareholders? If you currently own shares of Johnson & Johnson, when the company splits, you will own shares of both Johnson & Johnson – which will be the new pharmaceutical/medical device business – as well as shares of Kenvue, the new consumer health business.
For instance, one of the most valuable companies in the world, the Cupertino, California consumer technology giant Apple Inc. (NASDAQ:AAPL) has gone through five stock splits in its history. The most recent Apple stock split came in 2020 as the world was reeling from the impact of the coronavirus pandemic.
What happens to JNJ stock when the company splits? Once Johnson and Johnson splits, JNJ stock will only give traders and investors exposure to the medical device and pharmaceutical proceeds of the company.
Largest shareholders include Vanguard Group Inc, BlackRock Inc., State Street Corp, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, VFINX - Vanguard 500 Index Fund Investor Shares, Geode Capital Management, Llc, Morgan Stanley, State Farm Mutual Automobile Insurance Co, Spdr S&p 500 Etf Trust, and ...
Under the terms of the exchange offer, 8.0324 shares of Kenvue common stock will be exchanged for each share of Johnson & Johnson common stock accepted in the exchange offer.
Overall, the performance of JNJ stock with respect to the index has been quite volatile. Returns for the stock were 9% in 2021, 3% in 2022, and -11% in 2023. In comparison, returns for the S&P 500 have been 27% in 2021, -19% in 2022, and 24% in 2023 - indicating that JNJ underperformed the S&P in 2021 and 2023.
Is the split worth it? – Stock splits have no tangible impact on a company's total value—they simply create more shares at more affordable prices. Nor does a split change the total value of an investor's portfolio holding per se.
- Broadcom (NASDAQ:AVGO) is the most expensive stock on this list on a per-share basis. ...
- Deckers Outdoor (NYSE:DECK) is another that needs a stock split. ...
- Nvidia (NASDAQ:NVDA) is no stranger to the spotlight after gaining almost 2,000% over the past five years.
Date | Symbol | Split Ratio |
---|---|---|
Apr 5, 2024 | GLAD | 1 for 2 |
Apr 5, 2024 | EDBL | 1 for 20 |
Apr 4, 2024 | STKH | 1 for 10 |
Apr 3, 2024 | UCAR | 1 for 100 |
What does the J&J split mean for shareholders?
In early 2023, Johnson & Johnson completed an initial public offering of Kenvue. It plans to spin off the rest of the shares to shareholders later in the year. The J&J split means existing shareholders will receive shares of Kenvue in addition to their Johnson & Johnson stock.
For each share of Johnson & Johnson common stock that is validly tendered and not validly withdrawn by shareholders and that is accepted by Johnson & Johnson pursuant to the exchange offer, Johnson & Johnson will deliver 8.0324 shares of Kenvue common stock to or at the direction of any such tendering shareholder.
A stock split lowers its stock price but doesn't weaken its value to current shareholders. It increases the number of shares and might entice would-be buyers to make a purchase. The total value of the stock shares remains unchanged because you still own the same value of shares, even if the number of shares increases.
Holder | Shares | Date Reported |
---|---|---|
Vanguard Group Inc | 229,387,671 | Dec 30, 2023 |
Blackrock Inc. | 186,308,341 | Dec 30, 2023 |
State Street Corporation | 132,904,295 | Dec 30, 2023 |
Geode Capital Management, LLC | 51,256,785 | Dec 30, 2023 |
In 2003, Ethicon launched Vicryl Plus Antibacterial Sutures. The products prevent post-surgery infection within stitches. In 2006, Johnson & Johnson acquired Pfizer's consumer healthcare business and merged it with its consumer healthcare business group.
The split allows J&J's executives to focus more on developing innovations and expanding the businesses of medical technologies and pharmaceuticals. “We need to be a top-tier medical tech company and a top-tier pharmaceutical company, first and foremost,” Chief Financial Officer Joseph Wolk said.
Johnson & Johnson is splitting into two companies, separating the division that sells Band-Aids and Listerine, from its medical device and prescription drug business. Johnson & Johnson is peeling off a consumer health business that helped it become the world's biggest health care products maker.
Close | Chg | Chg % |
---|---|---|
$157.78 | -0.41 | -0.26% |
Cash on Hand as of December 2023 : $22.92 B
According to Johnson & Johnson's latest financial reports the company has $22.92 B in cash and cash equivalents. A company's cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Johnson & Johnson (Symbol: JNJ) has been named to the Dividend Channel ''S.A.F.E. 25'' list, signifying a stock with above-average ''DividendRank'' statistics including a strong 3.0% yield, as well as a superb track record of at least two decades of dividend growth, according to the most recent ''DividendRank'' report.
Should I buy or sell JNJ stock?
Johnson & Johnson has 13.06% upside potential, based on the analysts' average price target. Is JNJ a Buy, Sell or Hold? Johnson & Johnson has a conensus rating of Moderate Buy which is based on 7 buy ratings, 6 hold ratings and 0 sell ratings.
Johnson & Johnson isn't the safe stock it used to be
In the past, Johnson & Johnson may have been a good healthcare stock to comfortably hold in your portfolio. But that's no longer the case. Until there is a resolution to the talc-related issues, the stock is simply too big of a risk these days.
Disadvantages of a Stock Split
A company cannot rely on a stock split to increase its value or market cap. A stock split divides the existing shares, thus keeping the market cap the same as before. Not to forget, a company must invest some amount to conduct a stock split.
Stock Splits | Split Ratio | Shares |
---|---|---|
June 1990 | 2:1 | 51,200 |
Feb. 1993 | 2:1 | 102,400 |
March 1999 | 2:1 | 204,800 |
Feb. 2024 | 3:1 | 614,400 |
Splits are often a bullish sign since valuations get so high that the stock may be out of reach for smaller investors trying to stay diversified. Investors who own a stock that splits may not make a lot of money immediately, but they shouldn't sell the stock since the split is likely a positive sign.